Lab head, Translational Kidney Therapies @MonashCID researching Vasculitis, NETs, & the microbiome in autoimmune kidney diseases.Big supporter of women in STEM.
Happy to share our latest review on my favourite form of cell death....@SCSMonash@MonashCID Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis? frontiersin.org/article/10.3…
Don't miss your chance to share new findings at the 22nd International Vasculitis Workshop! If you have been waiting to submit your late breaking abstract, consider this is your friendly reminder.
Deadline: Wednesday 10 December, 2025
Submit: vasculitis-melbourne2026.com…
Fabulous collaboration between @SCSMonash@MonashCID@Hudson_Research and A/Prof Grant Logan from @CMRI_AUS harnessing gene therapy to deliver therapeutic doses of DNaseI to clear extracellular DNA release from NETs in experimental ANCA Vasculitis.
Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis?
@Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis.
See full report: insight.jci.org/articles/vie…
Time is critical in AAV: dampening kidney inflammation prevents damage
Why not target effector T cells - leave other T cells alone?
Our paper in @NDTSocial defines IL-7Ra as a target
doi.org/10.1093/ndt/gfae276
Anti-IL-7Ra Abs are in Phase 2 trials - alopecia @Q32Bio ?an AAV therapy
Today's #eyeSCANdy is an acellular scanning EM of a glomerulus from a biopsy with membranous glomerulonephritis, stage II showing a reticular pattern of the subepithelial GBM.
Photo courtesy of Dr. Stephen Bonsib. #renal#pathology
Great day out for the Bladder and Kidney Disease Symposium with @MHickey_IVM the Director of @MonashCID telling us how cells traffic through the glomerulus!
The horrifying reality of being a woman, perfectly summarised by @_CaitlinORyan
If you give even the slightest shit about women, watch it all. This is what it’s like.
Major academic publishers' revenue and what they pay authors and reviewers:
Revenue:
Elsevier: $3.9 billion
Springer Nature: $2 billion
Wolters Kluwer: $1.6 billion
Wiley: $1.8 billion
Taylor & Francis: $800 million
Sage: $500 million
They pay:
Authors: $0
Reviewers: $0
Love this time of year where we get to share graduation day with our students and colleagues! Congratulations to my colleague of 12 years Dr Peter Eggenhuizen and my Master Student Farhana Amreen from @MonashCID@SCSMonash@Monash_FMNHS !!🎓🎉
Dr Andrew Bray from @Monash_FMNHS explaining the patent cliff in the autoimmune landscape and the importance in developing oral therapies opposed to injectables @ImmuMon
Today is R U OK day in Australia but yesterday was the start of the Ethiopian New Year so we celebrated with our PhD student Yibeltal who is way from friends and family. Our “lab family” gave him the traditional yellow flowers- we spared him our attempt at traditional dancing!
Another great #ANZSN annual scientific meeting in beautiful Adelaide, home of Haighs chocolate and some of Australia’s best wine! Looking forward to the 60th Anniversary in Perth in 2025!